Seniors with recent shingles episodes are not likely to face recurrence, study suggests

Elderly adults who have had a single episode of shingles have a relatively low short-term risk for coming down with the painful skin condition again, regardless of vaccination status, new research confirms.

"This study's findings are important because we found that the risk of having a recurrent shingles episode is not as high as previous research indicates," Kaiser Permanente researcher Hung-Fu Tseng, Ph.D., said. “We now have empirical data that show the risk of recurrence is low among an elderly population who did not have compromised immune systems, regardless of their vaccination status."

Led by Tseng, investigators analyzed health records of more than 6,000 people over the age of 60 who had cases of shingles, and then monitored the patients over a two-year follow up period to look at recurrence. At the conclusion of the follow-up period, researchers observed fewer than 30 recurrent cases of shingles, and very little difference in the rate of recurrence among vaccinated and unvaccinated participants. The Centers for Disease Control and Prevention has recommends those aged 60 and over be vaccinated against shingles.

The findings were published Tuesday in the Journal of Infectious Diseases.

More in News

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in ...

Long-term care pharmacy Omnicare will not face charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces more ...

Long-term care providers should follow hospitals in adopting EHRs, government says ...

Healthcare providers have already exceeded the government's 2013 adoption goals for electronic health records, the Department of Health and Human Services announced Wednesday.

Five-day COPD treatment quells flare-ups, reduces side effects, researchers find

Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.